CharlesAndrewTernentMD
Colon & Rectal Surgery • Omaha, NEColon & rectal surgery doctor in Omaha, Nebraska and is affiliated with
Are you Dr. Ternent?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9850 Nicholas St
Suite 100
Omaha, NE 68114Phone+1 402-343-1122Fax+1 402-343-1122
Summary
- Dr. Charles Ternent, MD is a colorectal surgeon in Omaha, Nebraska. He is currently licensed to practice medicine in Nebraska, Iowa, and Florida. He is a Colon & rectal surgery doctor in Omaha at Nebraska and is affiliated with.
Education & Training
Creighton University School of MedicineClass of 1989
Certifications & Licensure
NE State Medical License 1995 - 2026
IA State Medical License 2023 - 2025
FL State Medical License 2005 - 2009
NY State Medical License 1992 - 1997
American Board of Colon and Rectal Surgery Colon & Rectal Surgery
American Board of Surgery Surgery
Publications & Presentations
PubMed
- Cost-Effectiveness of Total Neoadjuvant Therapy With Selective Nonoperative Management for Locally Advanced Rectal Cancer: Analysis of Data From the Organ Preservation...Maria Widmar, Mason McCain, Akriti Mishra Meza, Charles Ternent, Andrew Briggs
Journal of Clinical Oncology. 2025-02-20 - 57 citationsLong-Term Results of Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy: The Randomized Phase II OPRA Trial.Floris S Verheij, Dana M Omer, Hannah Williams, Sabrina T Lin, Li-Xuan Qin
Journal of Clinical Oncology. 2024-02-10 - 30 citationsOrgan Preservation and Survival by Clinical Response Grade in Patients With Rectal Cancer Treated With Total Neoadjuvant Therapy: A Secondary Analysis of the OPRA Rand...Hannah M Thompson, Dana M Omer, Sabrina Lin, Jin K Kim, Jonathan B Yuval
JAMA Network Open. 2024-01-02
Press Mentions
- Surveillance Intensity Comparison by Risk for T1NX Locally Excised Rectal Adenocarcinoma: A Cost-Effective AnalysisNovember 13th, 2019
